about
Is intravesical stent position a predictor of associated morbidity?Is absorption of irrigation fluid a problem in Thulium laser vaporization of the prostate? A prospective investigation using the expired breath ethanol test.How do stone attenuation and skin-to-stone distance in computed tomography influence the performance of shock wave lithotripsy in ureteral stone disease?Absorption of Irrigation Fluid During Thulium Laser Vaporization of the Prostate.Ectopic Adrenocortical Tissue in the Spermatic Cord in a 44-Year-old Man.Recurrent Dystrophic Calcification of the Prostatic Resection Cavity After Transurethral Resection of the Prostate: Clinical Presentation and Endoscopic Management.Metachronous Primary Adenocarcinoma of Distal and Proximal Ureter within Two Years.Aktuelle Entwicklungen und Trends in der Urologie.Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 PatientsSpoilt for Choice: A Survey of Current Practices of Surgical Urinary Stone Treatment and Adherence to Evidence-Based Guidelines among Swiss UrologistsIn-hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trialPredictability and Inducibility of Detachment of Prostatic Central Gland Tissue after Prostatic Artery Embolization: Post Hoc Analysis of a Randomized Controlled Trial[Urology: What Is Your Diagnosis?]Ejaculatory disorders after prostatic artery embolization: a reassessment of two prospective clinical trialsInformation on surgical treatment of benign prostatic hyperplasia on YouTube is highly biased and misleadingSymptoms Associated With Long-term Double-J Ureteral Stenting and Influence of BiofilmsOutcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial
P50
Q35590498-9DC99E42-B77F-4341-AB40-A65C134857CFQ35612006-8F21E809-39AE-41AF-B779-A486674A9360Q35706264-823E63D0-1691-48D9-A430-3178A9E5AAA5Q36268898-C2DEE3CA-A648-4AC4-BFA0-406124150A8DQ38833566-BBEFC963-20E1-4F56-A507-F1A89A5F8826Q40122987-2895EB0F-DD3E-4917-8AC5-D6C5E91DE66BQ40738854-A8232460-27F8-46F3-A5C3-F7EFD2C53873Q52866403-2ABF064B-A775-4CE0-BA39-BCCAD4CB3E0CQ64912539-DE31A6CE-FA7F-4563-9156-38ABEC4E1187Q88179833-ED18E9B2-A4EE-4EC5-A4E9-4132905D7C0BQ90038787-4212A45F-0D57-4A71-B131-DA8B3BD43FA7Q90713875-979E8433-1853-4948-B4D3-A5D042C8F87AQ91130012-DA664520-75E5-4DEB-B245-2C9938E06BDFQ91749061-1698B702-458F-4BFF-A64A-3171B1266587Q91778035-05E0FFE3-0B55-4F41-87F0-65EE94981727Q91959950-0A771782-B385-4084-9E24-B3110D1D0603Q93124093-E23E2990-E57B-4B46-BE78-E6E0462B8794Q93384266-DC61C326-3A1F-462F-A6C4-F975A3C1ED83
P50
description
investigador
@es
researcher
@en
name
Gautier Müllhaupt
@en
type
label
Gautier Müllhaupt
@en
prefLabel
Gautier Müllhaupt
@en
P108
P31
P496
0000-0002-5725-5608